NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

Mallinckrodt plc, a leading specialty biopharmaceutical company, announced that it has closed the sale of its global contrast media and delivery systems (CMDS) business to Guerbet in a transaction valued at approximately $270 million. The company's CMDS operations encompassed four manufacturing facilities and a total of approximately 1,000 employees spread…

news

China, already a global powerhouse in high-tech areas from solar panels to bullet trains, is turning its industrial might to the challenge of making more of its own drugs for a vast and ageing population. Given the 10 years or more it typically takes to bring a new medicine to…

news

Investment bank Lazard is working with Sanofi's management to prepare a sale or listing of its Merial animal health unit, aiming to land the leading advisory job for the deal, which could value the business at up 12 billion euros ($12.7 billion), sources familiar with the matter said. Lazard is…

news

Dr Reddy's Laboratories Ltd (DRL) today said the USFDA has extended the time-frame for replying to the warning letter issued to the company by about two weeks to December 7. The company also said that it is in the process of preparing responses to the letter on November 5 by…

news

Alkem Laboratories Ltd on Wednesday said it expects the contribution of the US sales as a share of overall revenue to double in the next five years, just as it has doubled in the last five years. International revenue, which was just 12.6% of the overall revenue in 2010-11, rose…

news

Kangmei Pharmaceutical Co Ltd says shares to halt trading from nov 27 pending announcement related to share private placement.   reuters.com

news

Lidds AB developed, with its drug development technology, a new drug candidate with docetaxel, a chemotherapy drug used to treat many different cancers.   reuters.com

news

Allergan PLC said on Wednesday it will not appeal to the U.S. Supreme Court a court ruling this year that blocked the company from discontinuing its top-selling Alzheimer's drug in favor of a pricier version. Allergan will also pay $172,000 in legal expenses under a settlement with New York Attorney…

news

As insurers, patients and governments across the world debate over the rising cost of healthcare, Swiss pharmaceutical major Roche has boldly launched two new drugs for late-stage breast cancer, pricing them higher than any other cancer medicine in the Indian market. Kadcyla and Perjeta, the new class of drugs launched…

news

The price of many drugs prescribed by U.S. dermatologists has skyrocketed over the past six years, far exceeding increases in overall health care costs and stretching patients' budgets in an era of high insurance deductibles, according to a new study from Florida. Of the 19 drugs analyzed, price increases between…